Acta neurochirurgica

Intracranial pressure changes and outcomes in the early phase of experimental subarachnoid hemorrhage: severity of subarachnoid hemorrhage and maximum intracranial pressure

Fujii K, Takeuchi S, Toyooka T et al. · 2026 Jun 20
Study Type: Experimental animal study (rat model)
Key Question: Does maximum ICP in the early phase of experimental SAH correlate with neurological outcome and SAH severity, and can it serve as a reliable severity classifier?
Key Findings:
  • Maximum ICP strongly correlated with neurological score, SAH grade, and 24-hour mortality across four groups (sham; mild <50 mmHg; moderate 50–149 mmHg; severe ≥150 mmHg)
  • Higher maximum ICP was associated with greater cortical and hippocampal neuronal damage, apoptosis, and oxidative stress on histology at 24 hours
  • Moderate ICP group (50–149 mmHg) identified as the most reproducible and clinically translatable tier for SAH research
Clinical Relevance: Establishes ICP monitoring as a valid severity-stratification tool in preclinical SAH models, which has implications for interpreting translational research underpinning future ICP-targeted therapies relevant to UK neurocritical care practice.
Limitations: Findings are confined to a rodent model and may not translate directly to human SAH pathophysiology or ICP dynamics.
Acta neurochirurgica

CT-positive traumatic brain injury in patients ≥ 80 years: mortality and 6-months functional outcome

Aarhus M, Netteland DF, Tverdal C et al. · 2026 Jun 20
Study Type: Retrospective cohort study
Key Question: Does neurosurgical intervention improve mortality and functional outcomes in patients aged ≥80 years with CT-confirmed traumatic brain injury?
Key Findings:
  • Neurosurgical intervention reduced 30-day mortality (HR 0.46, 95% CI 0.28–0.76) but conferred no survival benefit at one year (HR 0.84, 95% CI 0.63–1.12)
  • Favourable 6-month outcome (GOS 4–5) was similar between surgical (29%) and conservatively managed (34%) patients; preinjury dependency, age, ASA class, and injury severity were the strongest predictors of poor outcome
  • Delayed trephination for chronic subdural haematoma carried only 5% mortality, whereas acute craniotomy was associated with significantly worse outcomes
Clinical Relevance: This challenges routine surgical escalation in octogenarians with TBI, supporting a goals-of-care and functional-baseline approach to neurosurgical decision-making — directly relevant to MDT practice across UK major trauma centres.
Limitations: Single-centre retrospective design limits generalisability and introduces selection bias in surgical case allocation.
Acta neurochirurgica

Next-generation sequencing (NGS) analysis and age-based survival comparison among glioblastoma (GBM) patients: a two-center cohort study

Lee CO, Park SY, Yun Y et al. · 2026 Jun 23
Study Type: Retrospective two-centre cohort study
Key Question: Do younger and elderly GBM patients differ in molecular genetics (via NGS) and survival outcomes?
Key Findings:
  • Elderly patients (≥65 years) had significantly shorter median OS (11.0 vs 18.0 months; p=0.001); multivariate analysis confirmed age as independent adverse prognostic factor (HR 1.961, p=0.002)
  • MGMT methylation was more prevalent in elderly patients (p=0.009) and independently protective (HR 0.513, p=0.004); GTR and Stupp protocol completion also independently improved survival
  • No NGS-derived mutation (including ATRX, MET, CDK6 amplification) reached statistical significance between age groups after correction for multiple testing
Clinical Relevance: Supports continued MGMT methylation testing across all age groups in NHS GBM pathways, as elderly patients may particularly benefit from temozolomide-based regimens despite lower Stupp protocol completion rates.
Limitations: Small sample (n=124) limits statistical power to detect molecular differences between age groups, and non-significant NGS trends should be interpreted cautiously.
Acta neurochirurgica

Transient cerebellum-related network disruption characterizes postoperative cognitive changes after dominant hemisphere subtemporal meningioma resection

Liu Z, Li Y, Jiang J et al. · 2026 Jun 23
Study Type: Prospective cohort study
Key Question: Does dominant-hemisphere petroclival meningioma resection via the extradural subtemporal approach cause distinct postoperative cognitive changes, and what are the corresponding neuroimaging correlates?
Key Findings:
  • Dominant-side resection caused significant short-term cognitive decline across multiple domains (MMSE Δ−6.4, MoCA Δ−5.1, SDMT Δ−17.8); non-dominant-side resection did not
  • rs-fMRI identified reduced spontaneous activity in left thalamus, middle temporal gyrus, and middle frontal gyrus, with attenuated cerebello-cortical and cerebello-subcortical functional connectivity in cognitively impaired patients
  • Cognitive deficits and neuroimaging changes largely resolved by three months postoperatively
Clinical Relevance: For UK neurosurgeons managing skull base meningiomas, this highlights the need for structured preoperative counselling and postoperative cognitive monitoring in dominant-hemisphere cases, and supports three-month neuropsychological follow-up as a minimum standard.
Limitations: Very small sample (n=23, recruited over six months), limiting statistical power and generalisability.
Acta neurochirurgica

An agentic AI framework for integrated decision support and surgical planning in intracerebral hemorrhage

Kochuiev E, Kaliuzhka V, Markevych M et al. · 2026 Jun 23
Study Type: Retrospective validation study (single-centre, n=50)
Key Question: Can an agentic AI framework reliably replicate expert decision-making and surgical trajectory planning for spontaneous intracerebral haemorrhage?
Key Findings:
  • AI treatment recommendations agreed with expert consensus in 82% of cases (41/50; κ=0.71), with discrepancies concentrated in borderline surgical candidates
  • Automated trajectory planning generated feasible minimally invasive corridors in all 50 cases; median angular deviation from expert-defined trajectories was 7.6° (IQR 5.1–9.8°)
  • AI-generated trajectories demonstrated equal or superior safety margins to expert planning in the majority of evacuation candidates
Clinical Relevance: This framework could reduce operator-dependent variability in ICH surgical planning, relevant to UK centres managing high case volumes with variable subspecialty expertise across regional neurosurgical networks.
Limitations: Small retrospective single-centre dataset of 50 cases limits generalisability, and prospective clinical validation with patient outcome data is absent.
Acta neurochirurgica

Improved visual outcomes after endoscopic endonasal transsphenoidal surgery for pituitary macroadenomas: a single-arm meta-analysis

Gupta K, Ashraf M, Farahnak D et al. · 2026 Jun 24
Study Type: Single-arm meta-analysis (29 studies; n=2,943)
Key Question: What are the pooled postoperative visual field outcomes following endoscopic endonasal transsphenoidal surgery (EETS) for pituitary macroadenomas?
Key Findings:
  • Visual field improvement achieved in 79% of patients (95% CI: 73–84%); complete normalisation in 41% (95% CI: 29–53%)
  • Visual field deterioration was rare at 1% (95% CI: 0–1%); 19% remained unchanged
  • Pooled CSF leak rate was 7% (95% CI: 4–10%)
Clinical Relevance: These figures provide benchmark outcome rates directly applicable to preoperative counselling for pituitary macroadenoma patients in UK neurosurgical practice, where EETS is now the standard approach.
Limitations: Significant heterogeneity in visual field testing methodology and follow-up timing across included studies limits the validity of pooled estimates as standardised recovery benchmarks.
Acta neurochirurgica

Case study of monozygotic triplets with identical pineal cysts. Is pineal cyst hereditary condition?

Balasubramaniam N, Musil Z, Chroboková K et al. · 2026 Jun 24
Study Type: Case series with retrospective institutional database review
Key Question: Do genetic factors contribute to pineal cyst formation, and is there evidence for hereditary predisposition?
Key Findings:
  • Monozygotic male triplets each harboured morphologically identical 14 mm pineal cysts despite differing clinical presentations
  • Whole-exome sequencing identified a germline *HERC2* nonsense variant and a somatic *INO80E* frameshift mutation in cyst tissue, suggesting a possible two-hit oncogenic model
  • Institutional database review (n=243) revealed familial clustering in four unrelated families, with identical cyst sizes in three of four families — all affected relatives were first-degree
Clinical Relevance: Incidental pineal cysts are frequently encountered in UK neurosurgical practice; evidence of hereditary clustering may prompt clinician awareness when taking family histories, though current surveillance protocols remain unaffected.
Limitations: Causality cannot be established from a single case and small retrospective database review; ascertainment bias is likely.
Acta neurochirurgica

How I do it: pediatric lateral-type posterior fossa ependymoma resection

Horčičáková K, Táborský J, Trková K et al. · 2026 Jun 25
Study Type: Technical case report / operative "how I do it" description
Key Question: What surgical approach and technique achieves safe gross total resection of lateral-type posterior fossa ependymoma in a young child?
Key Findings:
  • Single case of a 2-year-old presenting with torticollis and vomiting, harbouring a cerebellopontine angle ependymoma
  • Gross total resection was achieved following pre-operative external ventricular drain insertion to manage hydrocephalus
  • Authors assert GTR as the primary determinant of prognosis in this tumour subtype
Clinical Relevance: Lateral-type posterior fossa ependymomas are rare and technically demanding; this operative description may inform surgical planning for paediatric neurosurgeons managing similar cases at UK specialist centres.
Limitations: Single-case technical report with no outcome data, follow-up, or comparative series — no generalisable conclusions can be drawn regarding efficacy or safety.

…and 40 more Neurosurgery articles in that week's digest.

Subscribers get the complete brief, every Monday.

Get the Neurosurgery digest in your inbox every Monday

4 weeks completely free, then £20/year. Cancel any time during your trial — no charge.

Start your free trial — Neurosurgery → No card needed to browse. We'll ask for payment details to start the trial.